Bohai Pharmaceuticals Group, Inc. (), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, announced that DailyFinance, an AOL Money and Finance site, just released an article by noted Wall Street columnist Gene Marcial on Bohai's potential for growth in China's expanding Traditional Chinese Medicine market.
Posted on September 20th, the article asserts that the approximately $125 billion in healthcare reform that the Chinese government aims to extend to help the entire domestic population by 2011, "should be a huge boon to Bohai Pharmaceuticals, which is just starting to catch the eye of some U.S. investors." The piece goes on to provide a glimpse into the 15 traditional pharmaceutical products that Bohai currently produces, all derived from herbal and organic sources in both prescription and over-the-counter products.
"Appearing in an online portal that is as well-known by US consumers as AOL's DailyFinance is an honor," said Mr. Hongwei Qu, President and Chief Executive Officer of Bohai Pharmaceuticals. "Bohai is pleased with the article and we believe the timing couldn't be better for both investors and consumers of Traditional Chinese Medicine. We anticipate our business model will provide an excellent opportunity to take advantage of the recent PRC mandated policies and multi-billion dollar stimulus packages designed, in part, to support the use of Traditional Chinese Medicine by the growing middle-class in China."
The author of the article, Gene Marcial, writes the "Inside Wall Street" column for DailyFinance; which previously ran for 28 years on BusinessWeek. Before joining BusinessWeek, Marcial wrote the columns "Heard on the Street" and "Abreast of the Market" for The Wall Street Journal.
No comments:
Post a Comment